To characterize the manner of epigenetic regulation by α2M* signaling, we treated a prostate cancer, glioblastoma, and melanoma cancer cell lines with C38 Mab and then stimulated with α2M* and acetate alone or in combination. The gene discussed is A2M; the disease is prostate carcinoma.